-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on Anavex Life Sciences, Maintains $24 Price Target

Benzinga·02/09/2026 19:32:24
Listen to the news
D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $24 price target.